Skip to main content

Advertisement

SpringerLink
Log in

New guidelines for reporting of tumor marker studies in breast cancer research and treatment: REMARK

  • Letter to the Editor
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bast RC Jr, Ravdin P, Hayes DF, Bates S, Fritsche H Jr, Jessup JM, Kemeny N, Locker GY, Mennel RG, Somerfield MR (2001) 2000 Update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19(6):1865–1878

    PubMed  Google Scholar 

  2. Bast RC Jr, Ravdin P, Hayes DF, Bates S, Fritsche H Jr, Jessup JM, Kemeny N, Locker GY, Mennel RG, Somerfield MR (2001) Errata:2000 Update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19:4185–4188

    Google Scholar 

  3. Hayes DF, Bast R, Desch CE, Fritsche H, Kemeny NE, Jessup J, Locker GY, Macdonald J, Mennel RG, Norton L, et al (1996) A tumor marker utility grading system (TMUGS): a framework to evaluate clinical utility of tumor markers. J Natl Cancer Inst 88:1456–1466

    PubMed  CAS  Google Scholar 

  4. Simon R, Altman DG (1994) Statistical aspects of prognostic factor studies in oncology. Br J Cancer 69:979–985

    PubMed  CAS  Google Scholar 

  5. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM (2005) REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer 93(4):387–391

    Article  PubMed  CAS  Google Scholar 

  6. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM (2005) REporting recommendations for tumour MARKer prognostic studies (REMARK). Eur J Cancer 41(12):1690–1696

    Article  PubMed  Google Scholar 

  7. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM (2005) Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst 97(16):1180–1184

    Article  PubMed  CAS  Google Scholar 

  8. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM (2005) REporting recommendations for tumor MARKer prognostic studies (REMARK). Nat Clin Pract Urol 2(8):416–422

    Article  PubMed  CAS  Google Scholar 

  9. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM (2005) Reporting recommendations for tumor marker prognostic studies. J Clin Oncol 23(36):9067–9072

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Breast Cancer Program, University of Michigan, Cancer Center 6312 CCGC 1500 East Medical Center Drive, 0942, Ann Arbor, MI, 48109-0942, USA

    Daniel F. Hayes, Stephen Ethier & Marc E. Lippman

Authors
  1. Daniel F. Hayes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephen Ethier
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marc E. Lippman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel F. Hayes.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hayes, D.F., Ethier, S. & Lippman, M.E. New guidelines for reporting of tumor marker studies in breast cancer research and treatment: REMARK. Breast Cancer Res Treat 100, 237–238 (2006). https://doi.org/10.1007/s10549-006-9253-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-006-9253-5

Keywords

Search

Navigation